| A Two-Part Study of Sativex� Oromucosal Spray for Relieving Uncontrolled Persistent Pain at any site of cancer related pain in Patients With Advanced Cancer | A Two-part, Placebo-controlled, Study of the Safety and Efficacy of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Have Inadequate Analgesia Even With Optimized Chronic Opioid Therapy. | CTRI/2012/11/003160 |
| Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO) | Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO) - BELCANTO | CTIS2024-518917-24-00 |
| Cannabinoids for Behavioral Problems in Children With ASD | Cannabinoids for Behavioral Problems in Autism Spectrum Disorder: A Double Blind, Randomized, Placebo-controlled Trial With Crossover. | NCT02956226 |
| Pilot study on the effect of cannabinoids THC + CBD on resistant spasticity in patients with chronic spinal cord injury. | Pilot study on the effect of cannabinoids THC + CBD on resistant spasticity in patients with chronic spinal cord injury. | EUCTR2022-001777-31-ES |
| Effects of cannabis components (THC and CBD) on motor and non-motor symptoms of Parkinson's disease: a placebo-controlled clinical study | Effect of THC and CBD cannabinoids combined on motor and non-motor symptoms of Parkinson's disease: a double-blind, randomized, placebo-controlled clinical trial (cpf study) | RBR-10n7gx74 |
| Excretion and side effects for tetrahydrocannabinol and cannabidiol (Sativex) among patients with chronic kidney disease and patients on dialysis. | Pharmacokinetics and side effects for tetrahydrocannabinol and cannabidiol (Sativex) among patients with chronic kidney disease and patients on dialysis. - PK cannabinoids | EUCTR2019-002786-35-DK |
| COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement | COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement | NCT03675971 |
| The Pharmacodynamics of Cannabinoid-Caffeine Combinations | A Double-Blind, Randomized, Placebo-Controlled, Within-Subject Crossover Study of the Effects of Combinations of Cannabinoids and Caffeine | NCT05478863 |
| Effect of Cannabis on E-Cigarette Use Behavior | Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics: Electronic Cigarette Use | NCT06609109 |
| Effect of Cannabis on Cigarette Use Behavior | Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics: Cigarette Use | NCT06609083 |
| Cannabinoids for Taxane Induced Peripheral Neuropathy | The Effect of Dispensed Cannabis on Taxane Induced Peripheral Neuropathy | NCT03782402 |
| Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids | Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System, Cognition and Neuronal Oscillations | NCT02487381 |
| A study that evaluates the effectiveness of oral combined THC/CBD for people with advanced cancer experiencing a range of symptoms. | Oral Medicinal cannabinoids to Relieve Symptom Burden in the Palliative care of Patients with Advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) | ACTRN12619000037101 |
| Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis | A Double-blind, Randomized, Placebo-controlled, Parallel-group Trial of the Efficacy and Safety of Nabiximols Oromucosal Spray as Add-on Therapy in Patients With Spasticity Due to Multiple Sclerosis | NCT04203498 |
| Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study | Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System and Brain Function | NCT02492074 |
| Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain | Dronabinol for the Reduction of Chronic Pain and Inflammation in People With Sickle Cell Disease | NCT05519111 |
| Interaction between opioids and cannabinoids in the treatment of fibromyalgia pain | Cannabis-opioid interaction in the treatment of fibromyalgia pain – an open label proof-of-concept study - SPIRAL study | EUCTR2019-001861-33-NL |
| Cannabinoids for Symptom Control in Advanced Cancer, an Open Label Prospective Clinical Trial in New South Wales (NSW) | Cannabinoids for Symptom Control in Advanced Cancer, an Open Label Prospective Clinical Trial in New South Wales (NSW) | ACTRN12619000265178 |
| Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial | Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial | NCT05632627 |
| Pilot Trial Proposal looking at the use of Cannabinoids for analgesia in chronic myocardial ischaemic chest pain, using Sativex Oromucosal Spray | In a patient with chronic ischaemic chest pain, will Sativex Oromucosal Spray reduce their pain | ACTRN12614000622606 |
| The effects of medicinal cannabinoids on driving | The effects of medicinal cannabinoids on driving in healthy adults with prior cannabis experience | ACTRN12616000414415 |
| A study to asses the effects of Nabiximols on spasticity associated with multiple sclerosis. | A randomized double-blind placebo-controlled study of nabiximols in patients with spasticity in multiple sclerosis - RELEASE MSS4 | EUCTR2020-004306-58-LT |
| A clinical trial as proof of principle of the analgesic effectiveness of cannabinoids on postoperative pain | | ISRCTN25994117 |
| A study that evaluates the effectiveness of oral medicinal cannabis for people with advanced cancer experiencing a range of symptoms. | Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: a double-blind, placebo controlled, randomised clinical trials of efficacy and safety of cannabidiol (CBD) | ACTRN12618001220257 |
| A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders | A Phase IIb Study of the Safety and Efficacy of Nabiximols in Subjects With Spasticity Due to Neuromyelitis Optica Spectrum Disorders: A Double-blind, Randomized, Placebo-Controlled, Crossover Study | NCT05974293 |
| A clinical trial adding Sativex (a cannabis-based medicine) to standard treatment, temozolomide, to find out if it is beneficial for patients whose glioblastoma brain tumour has returned after treatment | A randomised controlled phase II trial of temozolomide with or without cannabinoids in patientswith recurrent glioblastoma | ISRCTN11460478 |
| Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder | A Randomized, Double-blind, Parallel-group Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder | NCT04592159 |
| Spice II Plus: Acute toxicity of new synthetic cannabinoids and stimulant drugs | Spice II Plus: Acute toxicity of new synthetic cannabinoids and stimulant drugs - Spice II Plus | DRKS00005093 |
| Study of Sativex for the Treatment of Cancer Related Pain. | A double blind, randomized, placebo-controlled, parallelgroup study of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in relieving uncontrolled persistent chronic pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy. | EUCTR2009-016064-36-CZ |
| Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain | Inhaled PPP001 Versus Immediate-release Oral Opioids for the Management of Breakthrough Pain in Cancer Subjects: a Randomized, Open Label, Crossover, Comparison Study | NCT03564548 |
| Study of Sativex for the Treatment of Cancer Related Pain. | A double blind, randomized, placebo-controlled, parallel group study of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in relieving uncontrolled persistent chronic pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronicopioid therapy. | EUCTR2009-016065-29-CZ |
| A multicenter, non-comparative, open-label extension study to assess the long term safety of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in patients with uncontrolled persistent chronic cancer related pain. | A multicenter, non-comparative, open-label extension study to assess the long term safety of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctive therapy in patients with uncontrolled persistent chronic cancer related pain. | EUCTR2009-016529-32-BE |
| Cannabinoids in progressive inflammatory brain disease (CUPID) | The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial | ISRCTN62942668 |
| Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital | A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Explore The Safety And Therapeutic Potential Of Cannabinoids As An Adjunct For Reducing Pain (Carp)- TCH | NCT06834997 |
| Cannabinoids in Bipolar Affective Disorder | Cannabinoids in Bipolar Affective Disorder: A Controlled Pilot Study | NCT00397605 |
| Cannabinoids for Pain Control During Medical Abortion | Cannabinoid Analgesia for Medical Abortion: A Randomized Controlled Trial | NCT03604341 |
| A trial to test how efficient Nabiximols is for treatment of spacticity in patients with Multiple Sclerosis | A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis | EUCTR2020-003271-18-CZ |
| Investigating the effect of medicinal cannabis on the symptoms and side effects of chemotherapy in people with cancer. | The CANnabinoids in CANcer (CANCAN) trial: Investigating the effect of medicinal cannabis on symptoms and side effects of chemotherapy in people with cancer | ACTRN12622000419763 |
| Cannabinoid Supplementation on Vascular and Cognitive Function | The Effects of Cannabinoids on Vascular and Cognitive Function in Young and Old Healthy Adults. | NCT03295903 |
| A randomized multi-centre double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders (CANNA-TICS) | A randomized multi-centre double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders (CANNA-TICS) | EUCTR2016-000564-42-DE |
| A trial to test how efficient Nabiximols is for treatment of spacticity in patients with Multiple Sclerosis | A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis - Study in MS patient Naïve to treatment with Nabiximols | EUCTR2019-002625-29-GB |
| A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | A Two-part, Placebo-controlled, Study of the Safety and Efficacy of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Have Inadequate Analgesia Even With Optimized Chronic Opioid Therapy. | NCT01424566 |
| Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis | A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With Multiple Sclerosis | NCT04657666 |
| The effect of Cannabinoids on Oral Mucositis during Cancer treatment | The use of Cannabinoids and Photobiomobulation therapy in the prevention and control of radio-induced Oral Mucositis in patients with Head and Neck Cancer: A randomized controlled clinical trial | RBR-8g2q8q5 |
| Effect of CBD and THC substances present in the cannabis plant as maintenance therapy for parkinson's disease | Effect of THC and CBD cannabinoids combined as maintenance therapy for parkinson's disease: an open-label exploratory clinical trial (cpf study) | RBR-92v86nn |
| Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol) | Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoid Combination (?9 -Tetrahydrocannabinol (THC) and Cannabidiol (CBD) In 1:1 Ratio) | NCT01893424 |
| Glioma: Reducing Anxiety by conSuming cannabinoidS - GRASS study. Treating anxiety with CBD in glioma patients - A randomized-controlled trial | Glioma: Reducing Anxiety by conSuming cannabinoidS - GRASS study. Treating anxiety with CBD in glioma patients - A randomized-controlled trial - GRASS study: Treating anxiety with CBD in glioma patients | NL-OMON54278 |
